Literature DB >> 1969171

Benzodiazepine anti-conflict effects in Maudsley reactive (MR/Har) and non-reactive (MNRA/Har) rats.

R L Commissaris1, G M Harrington, H J Altman.   

Abstract

The Maudsley Reactive (MR/Har) and Non-Reactive (MNRA/Har) rat strains, bred originally by Broadhurst for differences in Open Field Defecation, also differ in their control (i.e., non-drug) behavior in the Conditioned Suppression of Drinking (CSD) conflict procedure, a second "model" behavior for the study of anxiety and/or emotionality in rats. The present studies compared the effects of diazepam and alprazolam on CSD behavior in these two strains of rats. In daily 10-min sessions, water-deprived rats were trained to drink from a tube that was occasionally electrified (0.2-0.5 mA), electrification being signaled by a tone. Both diazepam and alprazolam increased punished responding in a dose-related manner. The per cent increase in punished responding (for diazepam only) was comparable in the two strains; however, both statistical and empirical approaches indicated that the magnitude of the anti-conflict effect of benzodiazepines in MNRA/Har versus MR/Har rats was not related to differences in baseline (i.e., non-drug) punished responding. Based on the absolute change in shocks received, rats of the MNRA/Har strain exhibited a significantly greater anti-conflict effect following diazepam or alprazolam treatment than did rats of the MR/Har strain. These findings further the hypothesis that the behavioral differences exhibited by Maudsley MR/Har and MNRA/Har rat strains may constitute a genetically-based "animal model" for the study of emotionality and/or anxiety.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969171     DOI: 10.1007/bf02244595

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Effects of acute and chronic interactions of diazepam and d-amphetamine on punished behavior of rats.

Authors:  R D Ford; R H Rech; R L Commissaris; L Y Meyer
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

2.  RELATIVE POTENCIES OF BENZODIAZEPINES AS MEASURED BY THEIR EFFECTS ON CONFLICT BEHAVIOR.

Authors:  I GELLER
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-05-01

3.  The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination.

Authors:  I GELLER; J T KULAK; J SEIFTER
Journal:  Psychopharmacologia       Date:  1962-10-31

4.  Central and peripheral norepinephrine metabolism in rat strains selectively bred for differences in response to stress.

Authors:  J Slater; D A Blizard; L A Pohorecky
Journal:  Pharmacol Biochem Behav       Date:  1977-05       Impact factor: 3.533

5.  Comparison of anti-conflict drug effects in three experimental animal models of anxiety.

Authors:  C D Kilts; R L Commissaris; R H Rech
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Differences in benzodiazepine receptor binding in Maudsley reactive and Maudsley non-reactive rats.

Authors:  H A Robertson; I L Martin; J M Candy
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

7.  'Peripheral' and 'central' type benzodiazepine receptors in Maudsley rats.

Authors:  E Tamborska; T Insel; P J Marangos
Journal:  Eur J Pharmacol       Date:  1986-07-31       Impact factor: 4.432

8.  BEHAVIORAL-NEUROCHEMICAL CORRELATION IN REACTIVE AND NONREACTIVE STRAINS OF RATS.

Authors:  H S SUDAK; J W MAAS
Journal:  Science       Date:  1964-10-16       Impact factor: 47.728

9.  MR/Har and MNRA/Har Maudsley rat strains: differential response to chlordiazepoxide in a conflict task.

Authors:  R L Commissaris; T C McCloskey; G M Harrington; H J Altman
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

10.  The Har strains of rats: origins and characteristics.

Authors:  G M Harrington
Journal:  Behav Genet       Date:  1981-09       Impact factor: 2.805

View more
  7 in total

Review 1.  Stress and putative endogenous ligands for benzodiazepine receptors: the importance of characteristics of the aversive situation and of differential emotionality in experimental animals.

Authors:  A Fernández-Teruel; R M Escorihuela; A Tobeña; P Driscoll
Journal:  Experientia       Date:  1991-10-15

2.  Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics.

Authors:  S S Almeida; L M de Oliveira; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors.

Authors:  Sarah J Bailey; Miklos Toth
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

Review 4.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

5.  Differential effects of early stimulation and/or perinatal flumazenil treatment in young Roman low- and high-avoidance rats.

Authors:  A Fernández-Teruel; R M Escorihuela; P Driscoll; A Tobeña; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type.

Authors:  A M Perkins; U Ettinger; K Weaver; A Schmechtig; A Schrantee; P D Morrison; A Sapara; V Kumari; S C R Williams; P J Corr
Journal:  Transl Psychiatry       Date:  2013-04-16       Impact factor: 6.222

Review 7.  Modeling heritability of temperamental differences, stress reactivity, and risk for anxiety and depression: Relevance to research domain criteria (RDoC).

Authors:  Sarah M Clinton; Elizabeth A Shupe; Matthew E Glover; Keaton A Unroe; Chelsea R McCoy; Joshua L Cohen; Ilan A Kerman
Journal:  Eur J Neurosci       Date:  2021-03-24       Impact factor: 3.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.